Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Martin H. Adelman"'
Publikováno v:
Journal of Diabetes Science and Technology. 4:382-390
The nonsignificant reduction in macrovascular outcomes observed in Action to Control Cardiovascular Risk in Diabetes; Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation; and the Veterans Affairs Dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51231556521e0fcae9e8b7e2c0937770
https://doi.org/10.1177/193229681000400220
https://doi.org/10.1177/193229681000400220
Autor:
Martin H. Adelman, Scott V. Monte, Victor L. Yu, Bruce Lavin, Mendel E. Singer, Keith P. Klugman, Jerome J. Schentag, Thomas M. File, Joseph A. Paladino
Publikováno v:
International Journal of Antimicrobial Agents. 33:58-64
Patients with chronic obstructive pulmonary disease (COPD) may progress to community-acquired pneumonia (CAP), but there has been no formal study of the factors responsible. We studied the influence of severity of underlying lung disease, pathogen ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376001f61f178f5a2079e1f771a9131d
https://doi.org/10.1016/j.ijantimicag.2008.07.019
https://doi.org/10.1016/j.ijantimicag.2008.07.019
Autor:
Jenna L. Sunderlin, Joseph A. Paladino, Mendel E. Singer, Martin H. Adelman, Jerome J. Schentag
Publikováno v:
American Journal of Health-System Pharmacy. 65:1154-1159
Purpose. The influence of extended- spectrum β-lactams on gram-negative bacterial resistance was studied. Methods. Hospital pharmacists were asked to provide data on antimicrobial use and bacterial susceptibilities. Defined daily doses per 1000 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d3bf15ff2d78cd936c37224d3e3f38
https://doi.org/10.2146/ajhp070435
https://doi.org/10.2146/ajhp070435
Autor:
Mendel E. Singer, Jenna L. Sunderlin, Jerome J. Schentag, Joseph A. Paladino, Martin H. Adelman
Publikováno v:
American Journal of Health-System Pharmacy. 64:1633-1641
Purpose. Current knowledge and policies regarding vancomycin use and the clinical performance of vancomycin in U.S. hospitals were assessed. Methods. A questionnaire was sent to interested hospital pharmacists. An observational study of hospitalized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a132297552d880b95173b17f32d01e2a
https://doi.org/10.2146/ajhp060651
https://doi.org/10.2146/ajhp060651
Publikováno v:
Journal of the American Geriatrics Society. 55:651-657
OBJECTIVES To compare once-daily intramuscular cefepime with ceftriaxone controls. DESIGN Double-blind study. SETTING Six skilled nursing facilities. PARTICIPANTS Residents aged 60 and older with nursing home-acquired pneumonia. INTERVENTION Cultures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faf8d076756be4a7e8f90353f9750a49
https://doi.org/10.1111/j.1532-5415.2007.01152.x
https://doi.org/10.1111/j.1532-5415.2007.01152.x
Autor:
David M. Jacobs, G. Wilton, John K. Crane, Ryan K. Shields, Martin H. Adelman, Jerusha Taylor, Joseph A. Paladino, Jerome J. Schentag, Justin Bader
Publikováno v:
International journal of antimicrobial agents. 44(6)
Elevated minimum inhibitory concentrations (MICs) of vancomycin against meticillin-resistant Staphylococcus aureus (MRSA) and the emergence of heteroresistant S. aureus strains have led to increased use of anti-MRSA antibiotics other than vancomycin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5238d6743cb08d9a12e3b335d2950c4f
https://pubmed.ncbi.nlm.nih.gov/25282169
https://pubmed.ncbi.nlm.nih.gov/25282169
Autor:
Jerome J. Schentag, Joseph A. Paladino, Joseph L. Izzo, Paul Fitzpatrick, Stephen C. Hanson, Martin H. Adelman, Thomas J. Cumbo, Mary C. Birmingham, James R. Carr
Publikováno v:
Infection Control and Hospital Epidemiology. 18:255-259
In 1993, several departments at Millard Fillmore Health System joined efforts to initiate a new approach to infection control. The main emphasis of this program is to move infection control to a real-time mode to manage patient outcomes daily. The pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381e42412b4917bbaf49e859a5ace19a
https://doi.org/10.1086/647607
https://doi.org/10.1086/647607
Publikováno v:
Journal of diabetes science and technology. 4(2)
Background For microvascular outcomes, there is compelling historical and contemporary evidence for intensive blood glucose reduction in patients with either type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM). There is also strong evi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::010492cf442973fd70a4787071f1a732
https://pubmed.ncbi.nlm.nih.gov/20307399
https://pubmed.ncbi.nlm.nih.gov/20307399
Autor:
Nicole Paolini Albanese, Erin M. Slazak, Martin H. Adelman, Joseph A. Paladino, Scott V. Monte, Gauri Rao
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 49(2)
Objective To provide program methodology and outcomes data identifying the impact of clinical pharmacy services (CPSs) in patients with type 2 diabetes. Design Longitudinal pre–post cohort study. Setting Regional primary care group in Buffalo, NY,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::273208b0e8a9375184c35e5dd35e7675
https://pubmed.ncbi.nlm.nih.gov/19289346
https://pubmed.ncbi.nlm.nih.gov/19289346
Publikováno v:
DICP. 25:1050-1057
Traditional antibiotic dosage adjustments target predetermined serum concentrations, whereas a host of in vitro studies and recent clinical trials establish that bacteria vary in their susceptibility. Dual individualization, which considers the varia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56df49105bb2b7e688178e9535376027
https://doi.org/10.1177/106002809102501003
https://doi.org/10.1177/106002809102501003